Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Annals of the Rheumatic Diseases
|
December 17, 2008
The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
M Schiff, C Pritchard, J E Huffstutter, et al.
Annals of the Rheumatic Diseases
|
November 26, 2009
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
P Emery, P Durez, M Dougados, et al.
Free Radical Research
|
January 28, 2014
Myeloperoxidase and its products in synovial fluid of patients with treated or untreated rheumatoid arthritis
A Nzeusseu Toukap, C Delporte, C Noyon, et al.
Arthritis and Rheumatism
|
December 1, 2007
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis
D van der Heijde, L Klareskog, R Landewé, et al.
Annals of the Rheumatic Diseases
|
January 7, 2009
Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
R Westhovens, M Robles, A C Ximenes, et al.
Annals of the Rheumatic Diseases
|
August 9, 2011
Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes
J Bathon, M Robles, A C Ximenes, et al.
Arthritis and Rheumatism
|
May 28, 2011
Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate
M C Genovese, A Covarrubias, G Leon, et al.
Bone Marrow Transplantation
|
October 12, 1999
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease
A Tyndall, A Fassas, J Passweg, et al.
Annals of the Rheumatic Diseases
|
August 21, 2010
Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
P Machado, I Castrejon, W Katchamart, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Annals of the Rheumatic Diseases
|
December 17, 2008
The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
M Schiff, C Pritchard, J E Huffstutter, et al.
Annals of the Rheumatic Diseases
|
November 26, 2009
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
P Emery, P Durez, M Dougados, et al.
Free Radical Research
|
January 28, 2014
Myeloperoxidase and its products in synovial fluid of patients with treated or untreated rheumatoid arthritis
A Nzeusseu Toukap, C Delporte, C Noyon, et al.
Arthritis and Rheumatism
|
December 1, 2007
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis
D van der Heijde, L Klareskog, R Landewé, et al.
Annals of the Rheumatic Diseases
|
January 7, 2009
Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
R Westhovens, M Robles, A C Ximenes, et al.
Annals of the Rheumatic Diseases
|
August 9, 2011
Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes
J Bathon, M Robles, A C Ximenes, et al.
Arthritis and Rheumatism
|
May 28, 2011
Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate
M C Genovese, A Covarrubias, G Leon, et al.
Bone Marrow Transplantation
|
October 12, 1999
Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease
A Tyndall, A Fassas, J Passweg, et al.
Annals of the Rheumatic Diseases
|
August 21, 2010
Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
P Machado, I Castrejon, W Katchamart, et al.
Page
of 4